Stocktoria
MiNK Therapeutics, Inc. INKT
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-10-15
MiNK Therapeutics, Inc. statistics & valuation
Market cap$58.0M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -87.7% | -188.5% | -493.3% | -130.4% | -75.1% |
| Return on equity | 87.8% | 55.1% | 124.4% | 6975.1% | -127.1% |
| Current ratio | 1.06 | 0.72 | 0.32 | 1.61 | 2.41 |
Source: SEC EDGAR filings · CIK 0001840229 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.